Cation adjusted mueller hinton media

Manufactured by BD

Cation-adjusted Mueller Hinton (CAMH) media is a microbiological culture medium used for antimicrobial susceptibility testing. It is formulated to contain specific cation concentrations that can influence the activity of certain antimicrobial agents, providing a standardized environment for testing the susceptibility of microorganisms to antibiotics.

Automatically generated - may contain errors

Lab products found in correlation

Tryptic soy agar tsa, by BD (2 mentions) Phosphate buffered saline (pbs), by Lonza (2 mentions) Adenosine 5 triphosphate atp disodium salt hydrate, by Merck Group (1 mentions) Ampicillin sodium salt, by Avantor (1 mentions) E coli atcc 25922, by American Type Culture Collection (1 mentions) K pneumoniae atcc 13883, by American Type Culture Collection (1 mentions) P aeruginosa atcc 27853, by American Type Culture Collection (1 mentions) Vancomycin hydrochloride, by Merck Group (1 mentions) Neostigmine bromide, by Merck Group (1 mentions) Porcine mucin, by Merck Group (1 mentions) Linezolid, by LKT Laboratories (1 mentions) High resolution agarose, by Merck Group (1 mentions) Acetonitrile, by Merck Group (1 mentions)

Spelling variants of this product

Mueller-Hinton (10 citations)

2 protocols using cation adjusted mueller hinton media

Antimicrobial Susceptibility Testing Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols

E. coli ATCC 25922, K. pneumoniae ATCC 13883, A. baumannii ATCC 19606, and P. aeruginosa ATCC 27853 were obtained from the American Type Culture Collection (ATCC). A22 was obtained from Cayman Chemical Company, and CBR-4830 was synthesized as described previously [24 (link)]. Luria–Bertani (LB) media, cation-adjusted Mueller Hinton (CAMH) media, and tryptic soy agar (TSA) were obtained from Becton-Dickson. Ampicillin sodium salt was obtained from VWR, phosphate-buffered saline (PBS) was obtained from Lonza, and adenosine 5’-triphosphate (ATP) disodium salt hydrate was obtained from Sigma-Aldrich (St. Louis, MO, USA).

Bryan E.J., Sagong H.Y., Parhi A.K., Grier M.C., Roberge J.Y., LaVoie E.J, & Pilch D.S. (2022). TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens. Antibiotics, 11(5), 693.

+ Open protocol

+ Expand

Antimicrobial Resistance in Staphylococcus aureus

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

Clinical isolates of MSSA, MRSA-USA100, MRSA-USA300, VISA, VRSA, and LRSA were provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by the Biodefense and Emerging Infections Research Resources Repository (BEI Resources), NIAID, NIH. The BEI Resources Web site (https://www.beiresources.org ) describes the location of origin of each isolate. Luria−Bertani (LB) media was obtained from Millipore. Cation-adjusted Mueller Hinton (CAMH) media and tryptic soy agar (TSA) were obtained from Becton Dickson. Phosphate-buffered saline (PBS) was obtained from BioWhittaker and dimethyl sulfoxide (DMSO) was obtained from Fluka Analytical. High-resolution agarose, acetonitrile, trifluoroacetic acid (TFA), mouse serum, porcine mucin, neostigmine bromide, and vancomycin hydrochloride were obtained from Sigma. Linezolid was obtained from LKT Laboratories. TXA707, TXA709, and BOFP were synthesized as described previously.^{26 (link),36 (link)}

Bryan E., Ferrer-González E., Sagong H.Y., Fujita J., Mark L., Kaul M., LaVoie E.J., Matsumura H, & Pilch D.S. (2023). Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus. ACS chemical biology, 18(3), 629-642.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!